The challenges of product- and process-related impurities to an evolving biopharmaceutical industry
Bioanalysis
.
2013 Jan;5(2):123-6.
doi: 10.4155/bio.12.314.
Authors
Daniel G Bracewell
,
C Mark Smales
PMID:
23330553
DOI:
10.4155/bio.12.314
No abstract available
Publication types
Editorial
MeSH terms
Biopharmaceutics / trends*
Biotechnology / trends
Drug Discovery / trends
Drug Industry / trends*
Humans
Grants and funding
BB/G010307/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
BB/G010358/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom